The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions

被引:16
|
作者
Atkin, Catherine [1 ]
Reddy-Kolanu, Vinay [2 ]
Drayson, Mark T. [3 ]
Sapey, Elizabeth [1 ]
Richter, Alex G. [3 ]
机构
[1] Univ Birmingham, Inst Inflammat & Ageing, Birmingham Acute Care Res, Birmingham B15 2GW, W Midlands, England
[2] Queen Elizabeth Hosp, Dept Acute Med, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
关键词
monoclonal gammopathy of undetermined significance; acute medicine; infection; screening; renal dysfunction; CHAIN DEPOSITION DISEASE; MULTIPLE-MYELOMA; SIGNIFICANCE MGUS; GUIDELINES; MANAGEMENT; RISK; DIAGNOSIS; PROGRESSION; SURVIVAL; THERAPY;
D O I
10.1111/bjh.16487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monoclonal gammopathy of undetermined significance (MGUS) affects 3 center dot 2% of adults aged >50 years. MGUS carries a life-long risk of progression to multiple myeloma and causes complications including infection and renal impairment; common causes of hospital admission. This study aimed to assess MGUS prevalence in emergency medical hospital admissions. Patients were recruited from unselected emergency medical admissions in a hospital in the United Kingdom. Serum protein electrophoresis was performed, with immunofixation of abnormal results. Reason for admission and routine test results were recorded. After education about MGUS and myeloma, patients chose whether they wished to be informed of new diagnoses. A total of 660 patients were tested and 35 had a paraprotein suggestive of MGUS. The overall rate of MGUS was 5 center dot 3%. MGUS prevalence in those aged >50 years was 6 center dot 94%, higher than the previously published rate of 3 center dot 2% (P < 0 center dot 0005). There were higher rates in those with chronic kidney disease (13 center dot 75% vs. 4 center dot 14%, P = 0 center dot 002), heart failure (14% vs. 4 center dot 59%, P = 0 center dot 012), anaemia (8 center dot 96% vs. 3 center dot 41%, P = 0 center dot 003) or leucocytosis (9 center dot 33% vs. 3 center dot 04%, P = 0 center dot 002). In all, 96% of patients wished to be informed of their screening results. The prevalence of MGUS in emergency hospital admissions is higher than expected based on previous population-based rates. This may suggest a selected population for screening.
引用
收藏
页码:1127 / 1135
页数:9
相关论文
共 50 条
  • [1] Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
    Xu, Anping
    Guo, Tong
    Zhang, Shuping
    Luo, Houlong
    Shen, Mengxue
    Ye, Yinghui
    Ji, Ling
    HEMATOLOGY, 2024, 29 (01)
  • [2] Prevalence of monoclonal gammopathy of undetermined significance in Thailand
    Watanaboonyongcharoen, Phandee
    Nakorn, Thanyaphong Na
    Rojnuckarin, Ponlapat
    Lawasut, Panisinee
    Intragumtornchai, Tanin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (02) : 176 - 181
  • [3] Monoclonal gammopathy of undetermined significance
    Anguille, Sebastien
    Bryant, Christian
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (15) : 1345 - 1345
  • [4] In the Clinic Monoclonal Gammopathy of Undetermined Significance
    Gonsalves, Wilson I.
    Rajkumar, S. Vincent
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (12) : ITC177 - ITC192
  • [5] What is the significance of monoclonal gammopathy of undetermined significance?
    Atkin, Catherine
    Richter, Alex
    Sapey, Elizabeth
    CLINICAL MEDICINE, 2018, 18 (05) : 391 - 396
  • [6] Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis
    Huebel, K.
    Hallek, M.
    INTERNIST, 2013, 54 (06): : 709 - +
  • [7] Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance
    Hillengass, J.
    Weber, M-A
    Kilk, K.
    Listl, K.
    Wagner-Gund, B.
    Hillengass, M.
    Hielscher, T.
    Farid, A.
    Neben, K.
    Delorme, S.
    Landgren, O.
    Goldschmidt, H.
    LEUKEMIA, 2014, 28 (01) : 174 - 178
  • [8] Monoclonal gammopathy of undetermined significance and biological treatments: What should we do?
    Lemieux-Blanchard, Emilie
    JOINT BONE SPINE, 2017, 84 (06) : 651 - 653
  • [9] Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance
    Lakshman, Arjun
    Paul, Shilpa
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Greipp, Patricia T.
    Dispenzieri, Angela
    Gertz, Morie A.
    Buadi, Francis K.
    Lacy, Martha Q.
    Dingli, David
    Fonder, Amie L.
    Hayman, Suzanne R.
    Hobbs, Miriam A.
    Gonsalves, Wilson I.
    Hwa, Yi Lisa
    Kapoor, Prashant
    Leung, Nelson
    Go, Ronald S.
    Lin, Yi
    Kourelis, Taxiarchis V.
    Warsame, Rahma
    Lust, John A.
    Russell, Stephen J.
    Zeldenrust, Steven R.
    Kyle, Robert A.
    Kumar, Shaji K.
    LEUKEMIA, 2018, 32 (08) : 1811 - 1815
  • [10] Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men
    Cicero, Kara I.
    Joffe, Maureen
    Patel, Moosa
    Chiuzan, Codruta
    Pentz, Audrey
    Ruff, Paul
    Lentzsch, Suzanne
    Leng, Siyang
    Jacobson, Judith S.
    Rebbeck, Timothy R.
    Neugut, Alfred I.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (12) : 2192 - 2198